Benzothiazepine Anticancer Compounds with Alkoxy and Hydroxyl Modifications

The patent applies parameter changes by systematically modifying molecular parameters of the anticancer compounds, including: changing the R groups at specific positions in the chemical structure, varying the oxidation state (X=S or X=SO), adjusting the length and composition of alkyl chains (m=0-4), and modifying substituent patterns on aromatic rings. These parameter variations enable optimization of pharmacological properties while maintaining anticancer activity.

The patent creates composite molecular structures by combining multiple functional moieties: the benzothiazepine core structure, hydroxyl groups at positions 3,4,5, alkoxy substituents at position 2, amide linkages, and various R group substitutions. This composite approach allows simultaneous optimization of different pharmacological properties through the synergistic interaction of multiple structural elements.

The patent applies segmentation by dividing the synthesis process into distinct modular steps: (1) formation of the benzothiazepine core structure, (2) introduction of hydroxyl groups at positions 3,4,5, (3) addition of alkoxy substituents at position 2, (4) formation of amide linkages, and (5) introduction of various R groups. This modular approach allows independent optimization of each step and simplifies the overall synthesis process.

The patent applies preliminary action by establishing the core benzothiazepine structure with key functional groups (hydroxyls at 3,4,5 positions) before introducing the more complex R groups and substituents. This sequential approach allows the core structure to be optimized first, then built upon with additional functional elements, reducing overall synthesis complexity.